Lung cancer and radiofrequency ablation

被引:80
作者
Rose, Steven C.
Thistlethwaite, Patricia A.
Sewell, Patrick E.
Vance, Ralph B.
机构
[1] Univ Calif San Diego, Dept Radiol, Med Ctr, San Diego, CA 92103 USA
[2] Univ Calif San Diego, Dept Surg, Med Ctr, San Diego, CA 92103 USA
[3] Univ Mississippi, Med Ctr, Dept Radiol, Jackson, MS 39216 USA
[4] Univ Mississippi, Med Ctr, Dept Internal Med, Jackson, MS 39216 USA
关键词
NSCLC = non-small-cell lung cancer; PET = positron emission tomography; RF = rachofrequency;
D O I
10.1097/01.RVI.0000222707.44902.66
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Radiofrequency (RF) ablation is a recently developed technique for image-guided local destruction of selected tumors. Because the lung is a common site for cancer and usually has substantial functional reserve, RF ablation of lung cancers is an attractive option for minimally invasive treatment. The primary goal of the present review is to describe the natural history, staging systems, and conventional therapies for primary and secondary treatment of lung cancer, as well as the results of RF ablation in animal models and in humans for pulmonary applications, to clarify the appropriate role and limitations of this technology. The secondary goals are to review the principles of how RF works and to describe RF ablation techniques to familiarize interventionalists who may consider incorporating this technology into their practice and inform diagnostic radiologists of expected imaging findings and clinicians of their patients' anticipated courses and outcomes.
引用
收藏
页码:927 / 951
页数:25
相关论文
共 142 条
[1]   Combined radiofrequency ablation and adjuvant liposomal chemotherapy: Effect of chemotherapeutic agent, nanoparticle size, and circulation time [J].
Ahmed, M ;
Lukyanov, AN ;
Torchilin, V ;
Tournier, H ;
Schneider, AN ;
Goldberg, SN .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2005, 16 (10) :1365-1371
[2]   Radiofrequency ablation: Effect of surrounding tissue composition on coagulation necrosis in a canine tumor model [J].
Ahmed, M ;
Liu, ZJ ;
Afzal, KS ;
Weeks, D ;
Lobo, SM ;
Kruskal, JB ;
Lenkinski, RE ;
Goldberg, SN .
RADIOLOGY, 2004, 230 (03) :761-767
[3]  
Ahmed M, 2003, J VASC INTERV RADIOL, V14, P1045
[4]  
Ahrar K, 2003, J VASC INTERV RADIOL, V14, P1037
[5]   Percutaneous radiofrequency ablation of lung neoplasms: Initial therapeutic response [J].
Akeboshi, M ;
Yamakado, K ;
Nakatsuka, A ;
Hataji, O ;
Taguchi, O ;
Takao, M ;
Takeda, K .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2004, 15 (05) :463-470
[6]  
American Cancer Society, 2005, CANC FACTS FIG 2005
[7]  
[Anonymous], AJCC CANC STAGING MA
[8]   Percutaneous radiofrequency ablation of liver tumors with the LeVeen probe: Is roll-off predictive of response? [J].
Arata, MA ;
Nisenbaum, HL ;
Clark, TWI ;
Soulen, MC .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2001, 12 (04) :455-458
[9]   CT-guided radiofrequency ablation: A potential complementary therapy for patients with unresectable primary lung cancer - A preliminary report of 33 patients [J].
Belfiore, G ;
Moggio, G ;
Tedeschi, E ;
Greco, M ;
Cioffi, R ;
Cincotti, F ;
Rossi, R .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2004, 183 (04) :1003-1011
[10]   CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: Results in 32 tumors [J].
Bojarski, JD ;
Dupuy, DE ;
Mayo-Smith, WW .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2005, 185 (02) :466-471